Published in:
Open Access 01-12-2021 | Tissue Plasminogen Activator | Case report
An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug
Published in: BMC Pulmonary Medicine | Issue 1/2021
Login to get accessAbstract
Background
Coronavirus Disease 2019 (COVID-19) is a pandemic affecting all countries in the world. Italy has been particularly afflicted by the health emergency, and since the peak phase has passed, major concern regarding medium to long term complications due to COVID-19 is arising. Little is known in literature regarding thromboembolic complications once healed after COVID-19.
Case presentation
A 51-year-old patient recovered from COVID-19 pneumonia complicated by pulmonary embolism (PE) came to the hospital for palpitations and chest pain. Although he was on treatment dose of direct oral anticoagulation (DOAC), massive recurrent PE was diagnosed.
Conclusion
In the early post COVID-19 era, the question remains regarding the efficacy of DOACs in COVID-19 patients.